Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07630896 · ClinicalTrials.gov registry record · Phase 4
Post-op Prednisone and Glucose Monitoring in TKA
A Phase 4 study, sponsored by Columbia University.
- Not yet
- Registry status
- Phase 4
- Development phase
- 104
- Enrollment target
NCT07630896: Clinical Trial Phase 4 study, sponsored by Columbia University.
NCT07630896 is a Phase 4 study that has not yet begun recruiting, run by Columbia University. The registered enrollment target is 104 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (80% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07630896, a Phase 4 study, has not yet begun recruiting, sponsored by Columbia University.
- NOT YET RECRUITING
- Registry status
- Phase 4
- Development phase
- 104 participants
- Enrollment target
Study Summary
This study compares the efficacy of a 5-day post-operative oral prednisone regimen (40 mg daily) with the standard intraoperative steroid regimen, focusing on pain, swelling, range of motion, opioid use, and glucose levels monitored continuously.
Primary Outcome
Pain intensity at rest will be measured using the 11-point Numeric Rating Scale (NRS), ranging from 0 (no pain) to 10 (worst imaginable pain). The NRS is a validated and standardized tool for assessing patient-reported pain.
Interventions
- DEVICE Continuous Glucose Monitor
- DRUG Prednisone
- OTHER InkWell Health Tattoos
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2026-07-01 |
| Est. Completion | 2028-03 |
| Phase | Phase 4 |
What is known before NCT07630896 opens enrollment
NCT07630896 is an interventional study that assigns participants to a tested intervention. The registered 104 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (80% lower).
The record links to 0 conditions, and to 3 interventions - of which Continuous Glucose Monitor is the first listed.
NCT07630896 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07630896 about?
NCT07630896 is a clinical study titled "Post-op Prednisone and Glucose Monitoring in TKA". This study compares the efficacy of a 5-day post-operative oral prednisone regimen (40 mg daily) with the standard intraoperative steroid regimen, focusing on pain, swelling, range of motion, opioid use, and glucose levels monitored continuously.
What is the current status of trial NCT07630896?
This trial is currently not yet recruiting. It is a Phase 4 study. The enrollment target is 104 participants. The study started on 2026-07-01. Estimated completion is 2028-03.
What interventions are being tested in trial NCT07630896?
The interventions under investigation include: Continuous Glucose Monitor (DEVICE), Prednisone (DRUG), InkWell Health Tattoos (OTHER).
Who is sponsoring clinical trial NCT07630896?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07630896's enrollment target sits among peer trials
104 754th of 2000 higher than 1,241 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03403686 · 104 participants
Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)
- NCT04228367 · 104 participants · NA
JuggerStitch Post Market Clinical Follow-up Study
- NCT04268849 · 104 participants · Phase 3
Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient
- NCT04390724 · 104 participants
Optimizing Y90 Therapy for Radiation Lobectomy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI